Iambic reports Q3 2026 results, new HER2 data and planned 2027 registrational trialNov 16Regulatory decisionIambic Therapeutics, IncRocheUpdated
Roche registers fenebrutinib MS extension study; CEACAM5 trial recruitingNov 16Weekly roundup, 2 itemsfenebrutinibRoche
Roche posts SKYSCRAPER-01 results for tiragolumab/atezolizumab; registers Phase II Parkinson's trialNov 13Weekly roundup, 9 itemsalectinibastegolimab
FDA expanded pediatric use of entrectinib, cleared new pellet formulationNov 10Regulatory decisionentrectinibRoche
Zymeworks raises 2026 guidance after $250M Ziihera milestone, posts Roche deal for ZW209Nov 9Quarterly updateJazz PharmaceuticalsRoche
FDA approved alectinib for adjuvant ALK-positive NSCLC on April 18, 2024Nov 6Regulatory decisionalectinibRoche
Roche registers giredestrant Phase 3 trial; six other studies updateNov 6Weekly roundup, 16 itemsAbbViealectinibUpdated
GeoVax files for $5 million offering as Xbrane's ranibizumab approval standsNov 3Regulatory decisionGeoVax Labs, Inc.ranibizumab
Roche group registers Phase III UC trial, GA-AMD study; AD extension stays activeOct 30Weekly roundup, 7 itemsafimkibartastegolimab
Lilly-linked brain metastases trial posts results; two baricitinib studies completeOct 30Weekly roundup, 4 itemsabemaciclibadagrasibUpdated
Roche reports Phase 3 data showing sefaxersen cut proteinuria in IgA nephropathyOct 23Clinical readoutIonis PharmaceuticalsRoche
Roche adds Phase III trials in flu prophylaxis and diabetes, plus pediatric SMA study updateOct 22Weekly roundup, 6 itemsbaloxavir marboxilChugai PharmaceuticalUpdated
Alector schedules R&D webinar on wholly owned pipeline after Genentech GCase dealOct 19Clinical readoutAlector, Inc.Atrium TherapeuticsUpdated
MD Anderson trial of azacitidine plus venetoclax maintenance in AML stopped for low enrollmentOct 16Trial updateazacitidineRoche
Genentech's mycophenolate pregnancy registry listed as completed, last updated October 2026Oct 16Weekly roundup, 4 itemsAmneal Pharmaceuticals, LLCastegolimabUpdated
FDA clears supplemental efficacy application for Genentech's EnspryngOct 15Regulatory decisionRochesatralizumab
Genentech lists Phase Ib KRAS G12D trial; Roche-sponsored DLBCL study shows updateOct 9Weekly roundup, 9 itemsalectinibcisplatinUpdated
FDA clears atezolizumab combo for Stage III dMMR colon cancerOct 8Regulatory decisionatezolizumabatezolizumab and hyaluronidase-tqjs